GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Price-to-Funds-From-Operations

NGNE (Neurogene) Price-to-Funds-From-Operations : (As of Dec. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neurogene Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Neurogene Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.